Invest now
Transgene Biotek Profit & Loss Annual
BSE: 526139 | NSE: - | ISIN: INE773D01018 | Sector: Biotechnology & Drugs2.74 -0.06 (-2.14%)Updated : 09 Sep 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 0.95 | 1.48 | 0.94 | 6.06 |
| Other Net | 0.15 | 0.78 | 0.18 | 0.18 |
| Diluted Weighted Average Shares | 7.51 | 7.58 | 7.58 | 7.58 |
| Depreciation/ Amortization | 0.20 | 0.09 | 0.09 | 4.95 |
| Operating Income | -0.74 | -1.22 | -0.71 | -6.00 |
| Net Income | -1.65 | -0.68 | -0.66 | -6.01 |
| Income Availableto Com Excl Extra Ord | -1.65 | -0.68 | -0.66 | -6.01 |
| Other Operating Expenses Total | 0.61 | 1.08 | 0.54 | 0.74 |
| Net Income Before Taxes | -1.65 | -0.68 | -0.66 | -6.01 |
| Net Income After Taxes | -1.65 | -0.68 | -0.66 | -6.01 |
| Income Availableto Com Incl Extra Ord | -1.65 | -0.68 | -0.66 | -6.01 |
| Costof Revenue Total | 0.00 | 0.00 | 0.00 | 0.07 |
| Gross Profit | 0.21 | 0.26 | 0.23 | -0.01 |
| Interest Inc( Exp) Net- Non- Op Total | -1.06 | -0.24 | -0.13 | -0.18 |
| Unusual Expense( Income) | 0.00 | - | 0.00 | - |
| Diluted Net Income | -1.65 | -0.68 | -0.66 | -6.01 |
| Provisionfor Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | -1.65 | -0.68 | -0.66 | -6.01 |
| Total Revenue | 0.21 | 0.26 | 0.23 | 0.06 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 0.21 | 0.26 | 0.23 | 0.06 |
| Selling/ General/ Admin Expenses Total | 0.15 | 0.31 | 0.31 | 0.30 |
| Diluted Normalized EPS | -0.22 | -0.09 | -0.09 | -0.79 |
| Diluted EPS Excluding Extra Ord Items | -0.22 | -0.09 | -0.09 | -0.79 |
| Gain( Loss)on Saleof Assets | - | - | - | 0.00 |
*All figures in crores except per share values
Transgene Biotek Quick Links
Transgene Biotek Dividend Transgene Biotek Bonus Transgene Biotek News Transgene Biotek AGM Transgene Biotek Rights Transgene Biotek Splits Transgene Biotek Board Meetings Transgene Biotek Key Metrics Transgene Biotek Shareholdings Transgene Biotek Balance Sheet Transgene Biotek Cashflow Transgene Biotek Q1 Results Transgene Biotek Q2 Results Transgene Biotek Q3 Results Transgene Biotek Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
410.50+6.00(1.48%)
1,708.85+17.85(1.06%)
1,982.50+16.50(0.84%)
1,399.50-28.50 (-2.00%)
1,245.45-21.85 (-1.72%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.